Skip to main content
Premium Trial:

Request an Annual Quote

Illumina Installs BeadLab at Whitehead

NEW YORK, Sept. 15 (GenomeWeb News) - Illumina, of San Diego, has installed one of its BeadLab SNP genotyping platform's at MIT's Whitehead Institute, the company said today.


Researchers at the Whitehead will use the BeadLab platform for large-scale SNP genotyping projects, including the HapMap project.


Illumina said it first disclosed the installation in July, but withheld the identity of the purchaser.


The company has sold four other BeadLabs this year, to the Wellcome Trust Sanger Institute, Genome Quebec, Johns Hopkins University, and the National Center for Biochip Technology in Shanghai, China. Illumina said it has completed installations of all but the Shanghai platform.


The BeadLab costs between $1.5 million and $2 million and can produce up to 1 million genotypes per day, according to Illumina

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.